These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20875342

  • 1. Current treatment approaches for Paget's Disease of Bone.
    Brandi ML.
    Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
    Polyzos SA, Anastasilakis AD, Makras P, Terpos E.
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
    [Abstract] [Full Text] [Related]

  • 6. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
    Pirih FQ, Zablotsky M, Cordell K, McCauley LK.
    J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
    [Abstract] [Full Text] [Related]

  • 7. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
    Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R.
    Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
    [Abstract] [Full Text] [Related]

  • 8. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L, Merlotti D, Mossetti G, Rendina D, De Paola V, Martini G, Nuti R.
    Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
    [Abstract] [Full Text] [Related]

  • 9. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR, Minoofar PN.
    Adv Endocrinol Metab; 1995 Aug; 6():259-88. PubMed ID: 7671099
    [Abstract] [Full Text] [Related]

  • 10. Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.
    McCarthy HS, Marshall MJ.
    Expert Opin Ther Targets; 2010 Feb; 14(2):221-30. PubMed ID: 20055719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Medical management of Paget's disease of bone: indications for treatment and review of current therapies.
    Siris ES, Lyles KW, Singer FR, Meunier PJ.
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P94-8. PubMed ID: 17229018
    [Abstract] [Full Text] [Related]

  • 13. Paget's disease of bone.
    Siris ES.
    J Bone Miner Res; 1998 Jul; 13(7):1061-5. PubMed ID: 9661069
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Emerging issues with bisphosphonates.
    Reid IR.
    Rheum Dis Clin North Am; 2006 Nov; 32(4):691-702, vi. PubMed ID: 17288972
    [Abstract] [Full Text] [Related]

  • 17. Zoledronic acid for Paget's disease of bone.
    Maricic M.
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug treatment strategies for paget's disease: relieving pain and preventing progression.
    Merlotti D, Rendina D, Cavati G, Abate V, Falchetti A, Mingiano C, Nuti R, Gennari L.
    Expert Opin Pharmacother; 2023 Apr; 24(6):715-727. PubMed ID: 36961938
    [Abstract] [Full Text] [Related]

  • 20. Treatment of Paget's disease of bone with bisphosphonates.
    Mazières B.
    Rev Rhum Engl Ed; 1995 Feb; 62(2):72-8. PubMed ID: 7600075
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.